Ghost Tree Capital, LLC Immunic, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.54 - $14.26 $1.57 Million - $2.35 Million
-165,000 Closed
0 $0
Q4 2021

Feb 16, 2022
SELL
$7.34 - $10.25 $734,000 - $1.03 Million
-100,000 Reduced 37.74%
165,000 $1.58 Million
Q3 2020

Nov 16, 2020
BUY
$11.74 - $22.0 $3.11 Million - $5.83 Million
265,000 New
265,000 $4.92 Million

Others Institutions Holding IMUX

# of Institutions
70
Shares Held
56.2M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $37.9M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email